Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1455146

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1455146

Global Deep Brain Stimulation Devices Market Size, Share, Growth Analysis, By Product Type, By Application, By End-user - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Deep Brain Stimulation Devices Market size was valued at USD 1.41 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.14 billion by 2031, at a CAGR of 9.29% during the forecast period (2024-2031).

The market for deep brain stimulation devices is expanding significantly on a global scale due to numerous important considerations. The need for deep brain stimulation devices is growing as neurological conditions such essential tremor, Parkinson's disease, and dystonia become more common. Worldwide healthcare systems are now heavily burdened by neurological illnesses, which makes deep brain stimulation one of the most effective therapy choices available. Deep brain stimulation device technology has advanced, improving patient outcomes and expanding applications. Deep brain stimulation operations are now safer and more effective thanks to innovations like longer-lasting rechargeable batteries, better targeting systems, and improved stimulation parameters. The market is expanding as a result of patients' and healthcare professionals' rising awareness of deep brain stimulation as an effective therapeutic option. Deep brain stimulation is becoming more and more popular because of its many advantages, which include better quality of life, less reliance on medication, and symptom relief. Market expansion is also being aided by developed areas' advantageous reimbursement policies. Deep brain stimulation device manufacturers are seeing great potential to grow their market share in emerging economies due to rising healthcare costs and bettering healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segmental Analysis

Based on product type, application, end-user, and geography, the global market for deep brain stimulation devices may be divided. The market can be divided into rechargeable and non-rechargeable DBS devices based on the type of product. The market can be divided into segments according to application, such as essential tremor, dystonia, and Parkinson's disease. The market can be divided into hospitals, ambulatory surgery centers, and specialty clinics based on the end-user. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Deep Brain Stimulation Devices Market

Technological advancements in deep brain stimulation have improved patient results, increased the number of disorders that can be treated, and increased the therapy's overall efficacy and safety. Improved stimulation parameters, more accurate targeting systems, and the incorporation of sophisticated features like closed-loop systems and adaptive algorithms are examples of technological breakthroughs. These developments allow for more individualized treatment plans, improved symptom control, and fewer adverse effects.

Restraints in the Global Deep Brain Stimulation Devices Market

Because deep brain stimulation devices are intricate, expert neurosurgeons must undertake precise insertion procedures. These devices can have high costs associated with them, especially for the programming systems, leads, and hardware. The expense of the surgical treatment itself is further increased by the requirement for specialist equipment, resources in the operating room, and post-operative care. The high price makes it difficult to purchase and accessible, especially in areas with few healthcare services or insufficient insurance coverage.

Market Trends of the Global Deep Brain Stimulation Devices Market

The demand is being driven by the rising prevalence of neurological disorders: A surgical technique called deep brain stimulation (DBS) employs electrical stimulation to treat a range of neurological conditions, such as dystonia, essential tremor, and Parkinson's disease. The aging population, the rise in chronic illnesses, and the accumulation of environmental pollutants are some of the causes of this increase in prevalence. Since DBS devices are a highly successful treatment for many neurological disorders, the demand for them is being driven by the rising prevalence of these conditions.

Product Code: SQMIG35G2217

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Deep Brain Stimulation Devices Market by Product Type

  • Market Overview
  • Rechargeable DBS devices
  • non-rechargeable DBS devices

Global Deep Brain Stimulation Devices Market by Application

  • Market Overview
  • Parkinson's disease
  • essential tremor
  • dystonia

Global Deep Brain Stimulation Devices Market by End-user

  • Market Overview
  • Hospitals
  • ambulatory surgical centers
  • and specialty clinics

Global Deep Brain Stimulation Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sapiens Neuro (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beijing PINS Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SceneRay Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aleva Neurotherapeutics SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Functional Neuromodulation Ltd. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroPace, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuronetics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Brainsway Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synaptive Medical Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alpha Omega Engineering Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nexeon MedSystems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Autonomix Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Greatbatch Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SceneRay Corp. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saluda Medical Pty Ltd. (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!